Orthopedic MIS Comes of Age
Minimally invasive surgeries, once predicted to replace open surgeries across the board, have never taken off to a great degree, because MIS required more intricate and demanding manipulations that were uncomfortable, if not outright impossible for surgeons. It is against this background of MIS's stalled success that the adoption of minimally invasive techniques in that most unlikely of surgical specialties, orthopedics, and in particular, hip and knee joint replacements, is most amazing. A half decade after the introduction of the first true MIS procedures in total hip replacement, orthopedic surgeons have continued to push penetration rates of MIS well beyond what anyone might have expected.
You may also be interested in...
One of the hottest topics at the 2007 AAOS was the the trend toward resurfacing rather than completely replacing joints damaged by arthritis and other causes. There are a variety of metallic, synthetic and biologic methods used in hip, knee, shoulder and extremity joint resurfacing, many designed for younger patients who wish to remain active and avoid total joint replacement.
Recent clinical developments in the medical device industry, including developments in Artificial Limbs, Tissue-Engineered Therapy for ACL Tears, using Genes to Identify Early Atherosclerosis, and Stem Cell News.
Despite significant growth over the past several years, Encore Medical found it difficult to win over investors. So it has turned to private equity firm Blackstone Group to take it private, hoping that greater financial freedom will enable it to continue its aggressive growth.